Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
40
ICAD Quote, Financials, Valuation and Earnings
Last price:
$3.87
Seasonality move
:
0.58%
Day range:
$3.87 - $3.87
52-week range:
$1.19 - $4.02
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.24x
P/B ratio:
3.43x
Volume:
--
Avg. volume:
206.3K
1-year change:
182.48%
Market cap:
$105.5M
Revenue:
$19.6M
EPS (TTM):
-$0.20
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $29.7M | $33.6M | $19.8M | $17.3M | $19.6M | |
| Revenue Growth (YoY) | -5.24% | 13.27% | -41.13% | -12.54% | 13.22% | |
| Cost of Revenues | $8.3M | $9.4M | $3M | $2.5M | $3M | |
| Gross Profit | $21.4M | $24.2M | $16.8M | $14.8M | $16.6M | |
| Gross Profit Margin | 71.9% | 72.07% | 84.94% | 85.37% | 84.84% | |
| R&D Expenses | $8.1M | $9.2M | $5.5M | $5.2M | $6.6M | |
| Selling, General & Admin | $22.4M | $25.5M | $21.3M | $17.1M | $16.1M | |
| Other Inc / (Exp) | -$7.8M | -$386K | -$39K | -$14K | -$49K | |
| Operating Expenses | $30.7M | $35M | $27M | $22.5M | $22.9M | |
| Operating Income | -$9.4M | -$10.7M | -$10.2M | -$7.7M | -$6.3M | |
| Net Interest Expenses | $379K | $126K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$17.6M | -$11.2M | -$10M | -$7M | -$5.5M | |
| Earnings of Discontinued Ops. | -- | -- | -$3.7M | $2.2M | -- | |
| Income Tax Expense | $38K | $1K | -$116K | $20K | $98K | |
| Net Income to Company | -$17.6M | -$11.2M | -$13.7M | -$4.8M | -$5.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$17.6M | -$11.2M | -$13.7M | -$4.8M | -$5.6M | |
| Basic EPS (Cont. Ops) | -$0.80 | -$0.45 | -$0.54 | -$0.19 | -$0.21 | |
| Diluted EPS (Cont. Ops) | -$0.80 | -$0.45 | -$0.54 | -$0.19 | -$0.21 | |
| Weighted Average Basic Share | $22.1M | $24.8M | $25.2M | $25.6M | $26.4M | |
| Weighted Average Diluted Share | $22.1M | $24.8M | $25.2M | $25.6M | $26.4M | |
| EBITDA | -$16.5M | -$10.5M | -$9.5M | -$6.6M | -$4.9M | |
| EBIT | -$17.1M | -$11.1M | -$10M | -$7M | -$5.5M | |
| Revenue (Reported) | $29.7M | $33.6M | $19.8M | $17.3M | $19.6M | |
| Operating Income (Reported) | -$9.4M | -$10.7M | -$10.2M | -$7.7M | -$6.3M | |
| Operating Income (Adjusted) | -$17.1M | -$11.1M | -$10M | -$7M | -$5.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.6M | $7.5M | $4.3M | $5M | $4.9M | |
| Revenue Growth (YoY) | 31.95% | -12.97% | -42.39% | 14.31% | -1.62% | |
| Cost of Revenues | $2.4M | $2.2M | $791K | $841K | $685K | |
| Gross Profit | $6.3M | $5.3M | $3.5M | $4.1M | $4.2M | |
| Gross Profit Margin | 72.76% | 70.61% | 81.75% | 83.02% | 85.95% | |
| R&D Expenses | $2.2M | $2.3M | $1.5M | $1.5M | $1.5M | |
| Selling, General & Admin | $5.6M | $6.5M | $5.2M | $4M | $3.8M | |
| Other Inc / (Exp) | $2K | -$13K | $3K | $20K | $124K | |
| Operating Expenses | $7.8M | $8.8M | $6.8M | $5.6M | $5.3M | |
| Operating Income | -$1.5M | -$3.5M | -$3.2M | -$1.4M | -$1.1M | |
| Net Interest Expenses | $112K | $9K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$1.6M | -$3.5M | -$3.1M | -$1.2M | -$833K | |
| Earnings of Discontinued Ops. | -- | -- | -$687K | -- | -- | |
| Income Tax Expense | -- | $1K | $5K | $4K | -- | |
| Net Income to Company | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Basic EPS (Cont. Ops) | -$0.07 | -$0.14 | -$0.15 | -$0.05 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.07 | -$0.14 | -$0.15 | -$0.05 | -$0.03 | |
| Weighted Average Basic Share | $23.9M | $25.2M | $25.3M | $26.4M | $26.7M | |
| Weighted Average Diluted Share | $23.9M | $25.2M | $25.3M | $26.4M | $26.7M | |
| EBITDA | -$1.4M | -$3.4M | -$3M | -$1.3M | -$959K | |
| EBIT | -$1.6M | -$3.5M | -$3.1M | -$1.4M | -$1.1M | |
| Revenue (Reported) | $8.6M | $7.5M | $4.3M | $5M | $4.9M | |
| Operating Income (Reported) | -$1.5M | -$3.5M | -$3.2M | -$1.4M | -$1.1M | |
| Operating Income (Adjusted) | -$1.6M | -$3.5M | -$3.1M | -$1.4M | -$1.1M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $31.8M | $32.5M | $20.9M | $17.9M | $19.5M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $8.7M | $9.3M | $4.3M | $2.6M | $2.8M | |
| Gross Profit | $23.1M | $23.3M | $16.6M | $15.4M | $16.7M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $8.1M | $9.3M | $6.4M | $5.2M | $6.6M | |
| Selling, General & Admin | $21.9M | $26.5M | $22.1M | $15.8M | $15.9M | |
| Other Inc / (Exp) | -$40K | -$387K | -$11K | $2K | $55K | |
| Operating Expenses | $30.2M | $36M | $28.7M | $21.2M | $22.7M | |
| Operating Income | -$7M | -$12.7M | -$12.1M | -$5.9M | -$6M | |
| Net Interest Expenses | $361K | $36K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$7.4M | -$13.1M | -$11.8M | -$5.1M | -$5.1M | |
| Earnings of Discontinued Ops. | -- | -- | -$2.2M | $2.9M | -- | |
| Income Tax Expense | $12K | $2K | -$111K | $19K | $93K | |
| Net Income to Company | -$7.4M | -$13.1M | -$13.9M | -$2.3M | -$5.2M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$7.4M | -$13.1M | -$13.9M | -$2.3M | -$5.2M | |
| Basic EPS (Cont. Ops) | -$0.33 | -$0.53 | -$0.54 | -$0.12 | -$0.20 | |
| Diluted EPS (Cont. Ops) | -$0.33 | -$0.53 | -$0.54 | -$0.12 | -$0.20 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | -$6.4M | -$12.5M | -$11.2M | -$4.9M | -$4.7M | |
| EBIT | -$7M | -$13.1M | -$11.7M | -$5.3M | -$5.4M | |
| Revenue (Reported) | $31.8M | $32.5M | $20.9M | $17.9M | $19.5M | |
| Operating Income (Reported) | -$7M | -$12.7M | -$12.1M | -$5.9M | -$6M | |
| Operating Income (Adjusted) | -$7M | -$13.1M | -$11.7M | -$5.3M | -$5.4M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $8.6M | $7.5M | $4.3M | $5M | $4.9M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $2.4M | $2.2M | $791K | $841K | $685K | |
| Gross Profit | $6.3M | $5.3M | $3.5M | $4.1M | $4.2M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $2.2M | $2.3M | $1.5M | $1.5M | $1.5M | |
| Selling, General & Admin | $5.6M | $6.5M | $5.2M | $4M | $3.8M | |
| Other Inc / (Exp) | $2K | -$13K | $3K | $20K | $124K | |
| Operating Expenses | $7.8M | $8.8M | $6.8M | $5.6M | $5.3M | |
| Operating Income | -$1.5M | -$3.5M | -$3.2M | -$1.4M | -$1.1M | |
| Net Interest Expenses | $112K | $9K | -- | -- | -- | |
| EBT. Incl. Unusual Items | -$1.6M | -$3.5M | -$3.1M | -$1.2M | -$833K | |
| Earnings of Discontinued Ops. | -- | -- | -$687K | -- | -- | |
| Income Tax Expense | -- | $1K | $5K | $4K | -- | |
| Net Income to Company | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Basic EPS (Cont. Ops) | -$0.07 | -$0.14 | -$0.15 | -$0.05 | -$0.03 | |
| Diluted EPS (Cont. Ops) | -$0.07 | -$0.14 | -$0.15 | -$0.05 | -$0.03 | |
| Weighted Average Basic Share | $23.9M | $25.2M | $25.3M | $26.4M | $26.7M | |
| Weighted Average Diluted Share | $23.9M | $25.2M | $25.3M | $26.4M | $26.7M | |
| EBITDA | -$1.4M | -$3.4M | -$3M | -$1.3M | -$959K | |
| EBIT | -$1.6M | -$3.5M | -$3.1M | -$1.4M | -$1.1M | |
| Revenue (Reported) | $8.6M | $7.5M | $4.3M | $5M | $4.9M | |
| Operating Income (Reported) | -$1.5M | -$3.5M | -$3.2M | -$1.4M | -$1.1M | |
| Operating Income (Adjusted) | -$1.6M | -$3.5M | -$3.1M | -$1.4M | -$1.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $27.2M | $34.3M | $21.3M | $21.7M | $17.2M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $10M | $8.9M | $5.8M | $6.4M | $7.2M | |
| Inventory | $3.1M | $4.2M | $2.1M | $917K | $756K | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $1.9M | $3M | $1.6M | $699K | $1.3M | |
| Total Current Assets | $42.3M | $50.3M | $38.2M | $29.7M | $26.4M | |
| Property Plant And Equipment | $2.5M | $1.9M | $1.4M | $2.3M | $1.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.4M | $8.4M | $8.4M | $8.4M | $8.4M | |
| Other Intangibles | $889K | $683K | $264K | $148K | $101K | |
| Other Long-Term Assets | $1.5M | $899K | $3.3M | $849K | $757K | |
| Total Assets | $55.6M | $62.2M | $51.7M | $41.4M | $37.5M | |
| Accounts Payable | $5.3M | $5.6M | $2.8M | $1.7M | $1.8M | |
| Accrued Expenses | $4.6M | $2.8M | $1.2M | $1.4M | $1.7M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $726K | $889K | $217K | $188K | $229K | |
| Other Current Liabilities | -- | -- | $5.6M | -- | -- | |
| Total Current Liabilities | $16.8M | $15M | $13.5M | $6.7M | $7.6M | |
| Long-Term Debt | $7M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $25.1M | $15.7M | $16.8M | $8M | $8.9M | |
| Common Stock | $236K | $253K | $254K | $265K | $265K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $30.5M | $46.5M | $34.9M | $33.4M | $28.7M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $30.5M | $46.5M | $34.9M | $33.4M | $28.7M | |
| Total Liabilities and Equity | $55.6M | $62.2M | $51.7M | $41.4M | $37.5M | |
| Cash and Short Terms | $27.2M | $34.3M | $21.3M | $21.7M | $17.2M | |
| Total Debt | $7M | -- | -- | -- | -- | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $46.9M | $29.8M | $19.7M | $20.3M | $20M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $10.6M | $10.3M | $7.4M | $6.5M | $6.6M | |
| Inventory | $2.5M | $4.7M | $4.9M | $750K | $694K | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $2.2M | $3.1M | $2.3M | $1.5M | $769K | |
| Total Current Assets | $62.2M | $47.9M | $34.2M | $29M | $28.1M | |
| Property Plant And Equipment | $2.5M | $1.8M | $4.4M | $2.5M | $1.9M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $8.4M | $8.4M | $8.4M | $8.4M | $8.4M | |
| Other Intangibles | $831K | $640K | $436K | $136K | $90K | |
| Other Long-Term Assets | $1.6M | $104K | $55K | $299K | $962K | |
| Total Assets | $75.5M | $58.8M | $47.5M | $40.4M | $39.5M | |
| Accounts Payable | $1.3M | $2.7M | $1.9M | $635K | $1.1M | |
| Accrued Expenses | $5.8M | $5.1M | $4.2M | $1.8M | $2.4M | |
| Current Portion Of Long-Term Debt | $269K | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $847K | $887K | $569K | $216K | $234K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $14.1M | $14.5M | $12.9M | $6.2M | $7.7M | |
| Long-Term Debt | $6.7M | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $22.1M | $15.1M | $15.8M | $7.9M | $8.7M | |
| Common Stock | $251K | $253K | $254K | $265K | $273K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $53.4M | $43.8M | $31.7M | $32.5M | $30.8M | |
| Total Liabilities and Equity | $75.5M | $58.8M | $47.5M | $40.4M | $39.5M | |
| Cash and Short Terms | $46.9M | $29.8M | $19.7M | $20.3M | $20M | |
| Total Debt | $7M | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$17.6M | -$11.2M | -$13.7M | -$4.8M | -$5.6M | |
| Depreciation & Amoritzation | $577K | $557K | $521K | $409K | $624K | |
| Stock-Based Compensation | $2.8M | $2.8M | $1.7M | $1.3M | $883K | |
| Change in Accounts Receivable | -$302K | $969K | -$739K | $419K | -$776K | |
| Change in Inventories | -$533K | -$1M | -$1.2M | $1.5M | $161K | |
| Cash From Operations | -$7M | -$9.4M | -$12.8M | -$5M | -$3.9M | |
| Capital Expenditures | $474K | $587K | $534K | $1.3M | $519K | |
| Cash Acquisitions | -- | -- | -- | $4.5M | -- | |
| Cash From Investing | -$474K | -$587K | -$534K | $3.3M | -$519K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $7.7M | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -$7.4M | -$7.4M | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -$267K | -$59K | -- | -- | -- | |
| Cash From Financing | $19.3M | $17.1M | $355K | $2M | -- | |
| Beginning Cash (CF) | $15.3M | $27.2M | $34.3M | $21.3M | $21.7M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $11.9M | $7.1M | -$13M | $357K | -$4.5M | |
| Ending Cash (CF) | $27.2M | $34.3M | $21.3M | $21.7M | $17.2M | |
| Levered Free Cash Flow | -$7.5M | -$10M | -$13.3M | -$6.2M | -$4.5M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Depreciation & Amoritzation | $134K | $139K | $124K | $103K | $170K | |
| Stock-Based Compensation | $935K | $655K | $586K | $265K | $602K | |
| Change in Accounts Receivable | -$622K | -$1.7M | $1.5M | -$144K | $580K | |
| Change in Inventories | $647K | -$565K | $523K | $167K | $62K | |
| Cash From Operations | -$3.6M | -$4.4M | -$1.5M | -$1.2M | $60K | |
| Capital Expenditures | $262K | $161K | $122K | $206K | $257K | |
| Cash Acquisitions | -- | -- | -- | -- | $688K | |
| Cash From Investing | -$262K | -$161K | -$122K | -$206K | $431K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $23.5M | $126K | -- | -- | $2.3M | |
| Beginning Cash (CF) | $27.2M | $34.3M | $21.3M | $21.7M | $17.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.7M | -$4.5M | -$1.7M | -$1.4M | $2.8M | |
| Ending Cash (CF) | $46.9M | $29.8M | $19.7M | $20.3M | $20M | |
| Levered Free Cash Flow | -$3.8M | -$4.6M | -$1.7M | -$1.4M | -$197K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$7.4M | -$13.1M | -$13.9M | -$2.3M | -$5.2M | |
| Depreciation & Amoritzation | $562K | $562K | $506K | $388K | $691K | |
| Stock-Based Compensation | $3.3M | $2.5M | $1.6M | $995K | $1.2M | |
| Change in Accounts Receivable | -$3.5M | -$132K | $2.5M | -$1.2M | -$52K | |
| Change in Inventories | -$35K | -$2.2M | -$130K | $1.1M | $56K | |
| Cash From Operations | -$9.1M | -$10.3M | -$9.9M | -$4.6M | -$2.7M | |
| Capital Expenditures | $580K | $486K | $495K | $1.3M | $570K | |
| Cash Acquisitions | -- | -- | -- | -- | $688K | |
| Cash From Investing | -$580K | -$486K | -$495K | $3.2M | $118K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $42.4M | -$6.3M | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $32.7M | -$17.1M | -$10.1M | $621K | -$252K | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$9.7M | -$10.8M | -$10.4M | -$6M | -$3.3M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$1.6M | -$3.5M | -$3.8M | -$1.2M | -$833K | |
| Depreciation & Amoritzation | $134K | $139K | $124K | $103K | $170K | |
| Stock-Based Compensation | $935K | $655K | $586K | $265K | $602K | |
| Change in Accounts Receivable | -$622K | -$1.7M | $1.5M | -$144K | $580K | |
| Change in Inventories | $647K | -$565K | $523K | $167K | $62K | |
| Cash From Operations | -$3.6M | -$4.4M | -$1.5M | -$1.2M | $60K | |
| Capital Expenditures | $262K | $161K | $122K | $206K | $257K | |
| Cash Acquisitions | -- | -- | -- | -- | $688K | |
| Cash From Investing | -$262K | -$161K | -$122K | -$206K | $431K | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | $23.5M | $126K | -- | -- | $2.3M | |
| Beginning Cash (CF) | $27.2M | $34.3M | $21.3M | $21.7M | $17.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $19.7M | -$4.5M | -$1.7M | -$1.4M | $2.8M | |
| Ending Cash (CF) | $46.9M | $29.8M | $19.7M | $20.3M | $20M | |
| Levered Free Cash Flow | -$3.8M | -$4.6M | -$1.7M | -$1.4M | -$197K | |
Get ICAD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ICAD
Sector
P/E ratio
--
24.07x
PEG ratio
-0.29x
0.00x
P/B ratio
3.43x
1.81x
Price / LTM sales
5.24x
1.67x
Growth Metrics
ICAD
Sector
Revenue growth
-1.62%
4.06%
Earnings growth
--
7.49%
Revenue (5-year growth)
-8.95%
8.01%
Earnings forecast
-$0.06
-$0.20
Profitability
ICAD
Sector
Profitability FY 2024
$16.6M
$47.5M
Return on invested capital
-17.16%
-16.26%
Return on assets
-13.51%
-13.27%
Return on equity
-17.16%
-18.61%
Earnings Date
Last Earnings Date
May
13
Next Earnings Date
Aug
13
Estimated Next Earnings Date
Aug
12
Balance Sheet
ICAD
Sector
Total cash
$20M
$35.7M
Short term investments
--
$29.7M
Total assets
$37.5M
$106.9M
Long term debt
--
$7.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
71
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 59x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
68
MCRI alert for Jul 18
Monarch Casino & Resort [MCRI] is up 19.81% over the past day.
Sell
41
NEGG alert for Jul 18
Newegg Commerce [NEGG] is up 17.85% over the past day.
Buy
72
MNPR alert for Jul 18
Monopar Therapeutics [MNPR] is up 13.2% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
